T57CH17

Title 57 > T57CH17

Sections (7)

57-1701

TITLE 57 PUBLIC FUNDS IN GENERAL CHAPTER 17 CENTRAL CANCER REGISTRY FUND 57-1701. Creation of central cancer registry fund — Purpose. There is hereby created and established in the state treasury a fund to be known as the central cancer registry fund to which shall be deposited the revenues derived from the tax imposed in section 63-2506 , Idaho Code. All moneys now or hereafter in the central cancer registry fund are hereby dedicated for the purpose of contracting for and obtaining the services of a continuous registry of all cancer patients in the state of Idaho and maintaining cooperative exchange of information with other states providing similar cancer registry. The department of health and welfare is charged with the administration of this fund for the purposes specified herein. The amount of money credited to the central cancer registry fund from the tax imposed in section 63-2506 , Idaho Code, shall not exceed the distribution provided in section 63-2520 (b)(3), Idaho Code, and the current fiscal year’s appropriation, and any moneys in excess thereof derived from this tax shall be credited to the general fund. All claims against the fund shall be examined, audited and allowed in the manner now or hereafter provided by law for claims against the state of Idaho. History: [57-1701, added 1972, ch. 150, sec. 1, p. 324; am. 1975, ch. 56, sec. 1, p. 120; am. 1994, ch. 45, sec. 1, p. 73; am. 1995, ch. 67, sec. 2, p. 170; am. 2000, ch. 132, sec. 37, p. 345.]

57-1702

TITLE 57 PUBLIC FUNDS IN GENERAL CHAPTER 17 CENTRAL CANCER REGISTRY FUND 57-1702. Cancer control fund. There shall be established in the dedicated fund in the state treasury the cancer control fund, to which shall be credited the revenues derived from the tax distributed by subsection (b)(3) of section 63-2520 , Idaho Code. All moneys now or hereafter in the cancer control fund, to the extent appropriated, are hereby dedicated for the purpose of contracting for and obtaining the services to promote cancer control for the citizens of Idaho, through research, education, screening and treatment. The director of the department of health and welfare is charged with the administration of moneys appropriated from the fund unless otherwise provided by law. History: [57-1702, added 1979, ch. 33, sec. 1, p. 48; am. 1987, ch. 339, sec. 6, p. 719; am. 2014, ch. 115, sec. 4, p. 331.]

57-1703

TITLE 57 PUBLIC FUNDS IN GENERAL CHAPTER 17 CENTRAL CANCER REGISTRY FUND 57-1703. Cancer registry — Definitions. (1) Cancer means all in situ or malignant neoplasms diagnosed by histology, radiology, laboratory testing, clinical observation, autopsy or suggestible by cytology, but excluding basal cell and squamous cell carcinoma of the skin unless occurring on a mucous membrane and excluding in situ neoplasms of the cervix. (2) Reportable benign tumors means noncancerous neoplasms occurring in the brain, meninges, pineal gland or pituitary gland. (3) Confidential information refers to information which may identify a cancer patient, health care facility or health care provider. (4) Contractor means that individual, partnership, corporation or other entity performing cancer registry services under a contractual agreement with the department. (5) Department means the Idaho department of health and welfare. (6) Population-based refers to all cancers and reportable benign tumors diagnosed and/or treated within the state of Idaho by hospitals or other facilities providing screening, diagnostic or therapeutic services to patients with respect to cancer, and from physicians, surgeons, and all other health care providers diagnosing or providing treatment for cancer patients. History: [57-1703, added 1995, ch. 67, sec. 3, p. 171; am. 1999, ch. 76, sec. 1, p. 220.]

57-1704

TITLE 57 PUBLIC FUNDS IN GENERAL CHAPTER 17 CENTRAL CANCER REGISTRY FUND 57-1704. Establishment of cancer registry. (1) The department, or an authorized contractor of the department, shall maintain a uniform statewide population-based cancer registry system for the collection of data pertaining to the incidence, prevalence, management, survival, mortality, geographic distribution and risk factors associated with cancer and reportable benign tumors. (2) All cancers and reportable benign tumors diagnosed or treated in the state shall be reported to the department or the authorized contractor of the department. (3) Data reported to the cancer registry shall be available for use in aggregate form for analysis, benchmarking, and reports of Idaho’s cancer incidence, prevalence, management, survival, mortality, health status, geographic distribution, and risk factors in comparison to the nation. History: [57-1704, added 1995, ch. 67, sec. 4, p. 171.]

57-1705

TITLE 57 PUBLIC FUNDS IN GENERAL CHAPTER 17 CENTRAL CANCER REGISTRY FUND 57-1705. Participation in program. (1) Primary reporting: (a) Any hospital, outpatient surgery center, radiation treatment center, or treatment clinic diagnosing and/or treating a patient with cancer or a reportable benign tumor, on an inpatient or outpatient basis, shall report each case of cancer or reportable benign tumor to the department or the authorized contractor of the department within one hundred eighty (180) days of diagnosis. (b) Independent pathology and cytology laboratories shall report each diagnosis of cancer or reportable benign tumor to the department or the authorized contractor within one hundred eighty (180) days of specimen analysis. (2) Secondary reporting: In the event that a case of cancer or reportable benign tumor was not diagnosed or treated within a hospital, outpatient surgery center, radiation treatment center, or treatment clinic, the department or authorized contractor may request the case be reported by a physician’s office. (3) Each report of cancer or reportable benign tumor shall include information as defined by the department or the authorized contractor. (4) The department or authorized contractor of the department shall have physical access to all records which would identify reportable cases and/or establish characteristics, treatment or medical status of reportable cases in the event that there has been a failure to report as delineated in subsections (1), (2) and (3) of this section or for the purpose of subsequent quality control studies and research projects conducted by the department or the authorized contractor. (5) Nothing in this chapter shall prevent the department or authorized contractor from identifying and reporting cases using data linkages with death records, statewide cancer registries, and other potential sources. History: [57-1705, added 1995, ch. 67, sec. 5, p. 172.]

57-1706

TITLE 57 PUBLIC FUNDS IN GENERAL CHAPTER 17 CENTRAL CANCER REGISTRY FUND 57-1706. Confidentiality. (1) The department and authorized contractor will take measures to ensure that all identifying information is kept confidential. (2) The department and authorized contractor may enter into agreements to exchange confidential information with other states’ cancer registries in order to obtain complete reports of Idaho residents diagnosed or treated in other states and to provide information to other states regarding their residents diagnosed or treated in Idaho. (3) The department and authorized contractor may furnish confidential information to other cancer registries, federal cancer control programs, or health researchers in order to collaborate research studies. Disclosure of confidential information for research purposes must comply with policies and protocols of the department and/or authorized contractor of the department. History: [57-1706, added 1995, ch. 67, sec. 6, p. 172.]

57-1707

TITLE 57 PUBLIC FUNDS IN GENERAL CHAPTER 17 CENTRAL CANCER REGISTRY FUND 57-1707. Liability. (1) No action for damages arising from the disclosure of confidential or privileged information may be maintained against any reporting entities or employees of such entities that participate in good faith in the reporting of cancer registry data in accordance with this chapter. (2) No license of a health care facility or health care provider may be denied, suspended or revoked for the good faith disclosure of confidential or privileged information in accordance with this chapter. (3) The immunity granted in subsections (1) and (2) of this section shall not be construed to apply to the unauthorized disclosure of confidential or privileged information when such disclosure is due to gross negligence or willful misconduct of the reporting entities. History: [57-1707, added 1995, ch. 67, sec. 7, p. 173.]